Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

This Study Will Assess the Safety and Tolerability of AZD8418 After Single Increasing Oral Doses

This study has been terminated.
(Pre-Clinical Safety Tox Findings)
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01027234
First received: December 4, 2009
Last updated: May 25, 2010
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)